CBiPES: Difference between revisions
CSV import |
CSV import |
||
| Line 1: | Line 1: | ||
{{DISPLAYTITLE:CBiPES}} | |||
== | == Overview == | ||
CBiPES | [[File:CBiPES_Structure.svg|thumb|right|Chemical structure of CBiPES]] | ||
'''CBiPES''' is a chemical compound that acts as a selective positive allosteric modulator of the [[metabotropic glutamate receptor]] subtype 5 (mGluR5). It is primarily used in scientific research to study the role of mGluR5 in various physiological and pathological processes. | |||
== | == Chemical Properties == | ||
CBiPES | CBiPES is characterized by its unique chemical structure, which allows it to bind to the allosteric site of the mGluR5 receptor. This binding enhances the receptor's response to its natural ligand, [[glutamate]], without directly activating the receptor itself. | ||
== | == Mechanism of Action == | ||
CBiPES | CBiPES functions by modulating the activity of mGluR5 receptors. As a positive allosteric modulator, it increases the efficacy of glutamate binding, thereby potentiating the receptor's signaling pathways. This modulation can influence various [[neurotransmission]] processes in the [[central nervous system]]. | ||
== | == Research Applications == | ||
CBiPES is utilized in research to explore the therapeutic potential of mGluR5 modulation in treating neurological and psychiatric disorders. Studies have investigated its effects in models of [[schizophrenia]], [[anxiety]], and [[Parkinson's disease]]. | |||
== | == Related Compounds == | ||
CBiPES is part of a broader class of compounds known as allosteric modulators. Other related compounds include [[MPEP]] and [[ADX-47273]], which also target mGluR5 but with different modulatory effects. | |||
[[ | == Related Pages == | ||
[[Category: | * [[Metabotropic glutamate receptor]] | ||
[[Category: | * [[Allosteric modulator]] | ||
* [[Neurotransmission]] | |||
[[Category:Pharmacology]] | |||
[[Category:Neuroscience]] | |||
Latest revision as of 03:44, 13 February 2025
Overview[edit]

CBiPES is a chemical compound that acts as a selective positive allosteric modulator of the metabotropic glutamate receptor subtype 5 (mGluR5). It is primarily used in scientific research to study the role of mGluR5 in various physiological and pathological processes.
Chemical Properties[edit]
CBiPES is characterized by its unique chemical structure, which allows it to bind to the allosteric site of the mGluR5 receptor. This binding enhances the receptor's response to its natural ligand, glutamate, without directly activating the receptor itself.
Mechanism of Action[edit]
CBiPES functions by modulating the activity of mGluR5 receptors. As a positive allosteric modulator, it increases the efficacy of glutamate binding, thereby potentiating the receptor's signaling pathways. This modulation can influence various neurotransmission processes in the central nervous system.
Research Applications[edit]
CBiPES is utilized in research to explore the therapeutic potential of mGluR5 modulation in treating neurological and psychiatric disorders. Studies have investigated its effects in models of schizophrenia, anxiety, and Parkinson's disease.
Related Compounds[edit]
CBiPES is part of a broader class of compounds known as allosteric modulators. Other related compounds include MPEP and ADX-47273, which also target mGluR5 but with different modulatory effects.